These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 27476169

  • 1. Knockdown of miR-182 promotes apoptosis via regulating RIP1 deubiquitination in TNF-α-treated triple-negative breast cancer cells.
    Wo L, Lu D, Gu X.
    Tumour Biol; 2016 Oct; 37(10):13733-13742. PubMed ID: 27476169
    [Abstract] [Full Text] [Related]

  • 2. MiR-145 promotes TNF-α-induced apoptosis by facilitating the formation of RIP1-FADDcaspase-8 complex in triple-negative breast cancer.
    Zheng M, Wu Z, Wu A, Huang Z, He N, Xie X.
    Tumour Biol; 2016 Jul; 37(7):8599-607. PubMed ID: 26733177
    [Abstract] [Full Text] [Related]

  • 3. RIP1 upregulation promoted tumor progression by activating AKT/Bcl-2/BAX signaling and predicted poor postsurgical prognosis in HCC.
    Wang C, Yao B, Xu M, Zheng X.
    Tumour Biol; 2016 Nov; 37(11):15305-15313. PubMed ID: 27699664
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
    Li Z, Meng Q, Pan A, Wu X, Cui J, Wang Y, Li L.
    Oncotarget; 2017 Mar 21; 8(12):19455-19466. PubMed ID: 28038450
    [Abstract] [Full Text] [Related]

  • 5. Tumor suppressor role of microRNA-1296 in triple-negative breast cancer.
    Phan B, Majid S, Ursu S, de Semir D, Nosrati M, Bezrookove V, Kashani-Sabet M, Dar AA.
    Oncotarget; 2016 Apr 12; 7(15):19519-30. PubMed ID: 26799586
    [Abstract] [Full Text] [Related]

  • 6. Non-Specific Blocking of miR-17-5p Guide Strand in Triple Negative Breast Cancer Cells by Amplifying Passenger Strand Activity.
    Jin YY, Andrade J, Wickstrom E.
    PLoS One; 2015 Apr 12; 10(12):e0142574. PubMed ID: 26629823
    [Abstract] [Full Text] [Related]

  • 7. Lapatinib increases motility of triple-negative breast cancer cells by decreasing miRNA-7 and inducing Raf-1/MAPK-dependent interleukin-6.
    Hsiao YC, Yeh MH, Chen YJ, Liu JF, Tang CH, Huang WC.
    Oncotarget; 2015 Nov 10; 6(35):37965-78. PubMed ID: 26513016
    [Abstract] [Full Text] [Related]

  • 8. MicroRNA-301b promotes cell proliferation and apoptosis resistance in triple-negative breast cancer by targeting CYLD.
    Song H, Li D, Wu T, Xie D, Hua K, Hu J, Deng X, Ji C, Deng Y, Fang L.
    BMB Rep; 2018 Nov 10; 51(11):602-607. PubMed ID: 30269739
    [Abstract] [Full Text] [Related]

  • 9. Epigenetic silencing of miR-200c in breast cancer is associated with aggressiveness and is modulated by ZEB1.
    Damiano V, Brisotto G, Borgna S, di Gennaro A, Armellin M, Perin T, Guardascione M, Maestro R, Santarosa M.
    Genes Chromosomes Cancer; 2017 Feb 10; 56(2):147-158. PubMed ID: 27717206
    [Abstract] [Full Text] [Related]

  • 10. The involvement of β-actin in the signaling of transmembrane TNF-α-mediated cytotoxicity.
    Chen H, Xiao L, Zhang H, Liu N, Liu T, Liu L, Hu X, Yan D, Yang K, Yin B, Wang J, Li Q, Li Z.
    J Leukoc Biol; 2011 Jun 10; 89(6):917-26. PubMed ID: 21402772
    [Abstract] [Full Text] [Related]

  • 11. lncRNA GAS5-promoted apoptosis in triple-negative breast cancer by targeting miR-378a-5p/SUFU signaling.
    Zheng S, Li M, Miao K, Xu H.
    J Cell Biochem; 2020 Mar 10; 121(3):2225-2235. PubMed ID: 31692053
    [Abstract] [Full Text] [Related]

  • 12. Triad3A regulates ubiquitination and proteasomal degradation of RIP1 following disruption of Hsp90 binding.
    Fearns C, Pan Q, Mathison JC, Chuang TH.
    J Biol Chem; 2006 Nov 10; 281(45):34592-600. PubMed ID: 16968706
    [Abstract] [Full Text] [Related]

  • 13. The LEF1/CYLD axis and cIAPs regulate RIP1 deubiquitination and trigger apoptosis in selenite-treated colorectal cancer cells.
    Wu P, Shi KJ, An JJ, Ci YL, Li F, Hui KY, Yang Y, Xu CM.
    Cell Death Dis; 2014 Feb 27; 5(2):e1085. PubMed ID: 24577083
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells.
    Yu T, Liu M, Luo H, Wu C, Tang X, Tang S, Hu P, Yan Y, Wang Z, Tu G.
    J Steroid Biochem Mol Biol; 2014 Sep 27; 143():392-403. PubMed ID: 24874276
    [Abstract] [Full Text] [Related]

  • 16. LINC01096 knockdown inhibits progression of triple-negative breast cancer by increasing miR-3130-3p.
    Wang GP, Mou ZL, Xu YY, Liu GX, Wang DM, Zhang HP.
    Eur Rev Med Pharmacol Sci; 2019 Sep 27; 23(17):7445-7456. PubMed ID: 31539132
    [Abstract] [Full Text] [Related]

  • 17. Cellular IAP proteins and LUBAC differentially regulate necrosome-associated RIP1 ubiquitination.
    de Almagro MC, Goncharov T, Newton K, Vucic D.
    Cell Death Dis; 2015 Jun 25; 6(6):e1800. PubMed ID: 26111062
    [Abstract] [Full Text] [Related]

  • 18. RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer.
    Li M, Li AQ, Zhou SL, Lv H, Wei P, Yang WT.
    J Exp Clin Cancer Res; 2020 May 24; 39(1):92. PubMed ID: 32448269
    [Abstract] [Full Text] [Related]

  • 19. MiR-128 regulation of glucose metabolism and cell proliferation in triple-negative breast cancer.
    Xiao M, Lou C, Xiao H, Yang Y, Cai X, Li C, Jia S, Huang Y.
    Br J Surg; 2018 Jan 24; 105(1):75-85. PubMed ID: 29116653
    [Abstract] [Full Text] [Related]

  • 20. CircWAC induces chemotherapeutic resistance in triple-negative breast cancer by targeting miR-142, upregulating WWP1 and activating the PI3K/AKT pathway.
    Wang L, Zhou Y, Jiang L, Lu L, Dai T, Li A, Chen Y, Zhang L.
    Mol Cancer; 2021 Mar 01; 20(1):43. PubMed ID: 33648498
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.